UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3

Diabetes, obesity & metabolism, 2016-11, Vol.18 (11), p.1081-1088

2016

Volltextzugriff (PDF)

Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action

Diabetes, obesity & metabolism, 2016-10, Vol.18 (S2), p.3-16

2016

Volltextzugriff (PDF)

Primary care physician beliefs about insulin initiation in patients with type 2 diabetes

International journal of clinical practice (Esher), 2008-06, Vol.62 (6), p.860-868

2008

Volltextzugriff (PDF)

Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial

Diabetes, obesity & metabolism, 2016-11, Vol.18 (11), p.1055-1064

2016

Volltextzugriff (PDF)

A randomized clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 1

Diabetes, obesity & metabolism, 2016-10, Vol.18 (S2), p.25-33

2016

Volltextzugriff (PDF)

Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes

Diabetes, obesity & metabolism, 2016-10, Vol.18 (S2), p.50-58

2016

Volltextzugriff (PDF)

A randomized clinical trial of basal insulin peglispro vs NPH in insulin-naïve patients with type 2 diabetes: the IMAGINE 6 trial

Diabetes, obesity & metabolism, 2016-10, Vol.18 (S2), p.34-42

2016

Volltextzugriff (PDF)

Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes

Diabetes, obesity & metabolism, 2016-10, Vol.18 (S2), p.17-24

2016

Volltextzugriff (PDF)

Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes

European journal of endocrinology, 2010-08, Vol.163 (2), p.217-223

2010

Volltextzugriff (PDF)

A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetes

Diabetic medicine, 2010-02, Vol.27 (2), p.181-188

2010

Volltextzugriff (PDF)

Glucodynamics of long-acting basal insulin peglispro compared with insulin glargine at steady state in patients with type 1 diabetes: substudy of a randomized crossover trial

Diabetes, obesity & metabolism, 2016-11, Vol.18 (11), p.1065-1071

2016

Volltextzugriff (PDF)

Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycaemic control in T1DM and T2DM

Diabetes, obesity & metabolism, 2014-04, Vol.16 (4), p.351-356

2014

Volltextzugriff (PDF)

CA-013: Réduction des hypoglycémies nocturnes avec l'insuline basale peglispro (BIL) comparée à l'insuline glargine (GL) : analyses poolées de 5 études contrôlées randomisées

Diabetes & metabolism, 2016-03, Vol.42, p.A38-A38

2016

Volltextzugriff (PDF)

Addition of insulin lispro protamine suspension or insulin glargine to oral type 2 diabetes regimens: a randomized trial

Diabetes, obesity & metabolism, 2010-10, Vol.12 (10), p.916-922

2010

Volltextzugriff (PDF)

CA-018: Enzymes hépatiques et contenu hépatique en graisse (CHG) – Résultats des essais cliniques de l'insuline Peligspro (BIL)

Diabetes & metabolism, 2016-03, Vol.42, p.A39-A40

2016

Volltextzugriff (PDF)

PO31 Amélioration du contrôle glycémique avec l’insuline basale LY2605541 comparée à l’insuline basale glargine malgré une réduction des doses des bolus d’insuline chez des patients présentant un diabète de type 1

Diabetes & metabolism, 2014-03, Vol.40, p.A28-A28

2014

Volltextzugriff (PDF)

A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents

Diabetes, obesity & metabolism, 2006-07, Vol.8 (4), p.448-455

2006

Volltextzugriff (PDF)

Diabetes and pregnancy. Factors associated with seeking pre-conception care

Diabetes care, 1995-02, Vol.18 (2), p.157-165

1995

Volltextzugriff (PDF)

Why Do Older Women with Diabetes Have an Increased Fracture Risk?

The journal of clinical endocrinology and metabolism, 2001-01, Vol.86 (1), p.29-31

2001

Volltextzugriff (PDF)

Cardiovascular Disease in the Diabetic Woman

The journal of clinical endocrinology and metabolism, 1999-06, Vol.84 (6), p.1835-1838

1999

Volltextzugriff (PDF)

The influence of treatment modality and ethnicity on attitudes in type 2 diabetes

Diabetes care, 2000-03, Vol.23 (3), p.313-318

2000

Volltextzugriff (PDF)

The safety of injecting insulin through clothing

Diabetes care, 1997-03, Vol.20 (3), p.244-247

1997

Volltextzugriff (PDF)

Altered myosin light-chain phosphorylation in resting platelets from premenopausal women with diabetes

Metabolism, clinical and experimental, 2001-02, Vol.50 (2), p.151-156

2001

Volltextzugriff (PDF)

Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Diabetes care, 2005-07, Vol.28 (7), p.1547-1554

2005

Volltextzugriff (PDF)

An update on perioperative management of diabetes

Archives of internal medicine (1960), 1999-11, Vol.159 (20), p.2405

1999

Volltextzugriff (PDF)

1 – 25 von 332

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(272)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(100)
Humans
(86)
Female
(62)
Male
(55)
Endocrinology & Metabolism
(47)
Adult
(44)
Middle Aged
(40)
Biological And Medical Sciences
(37)
Diabetes
(34)
Medical Sciences
(33)
Arts & Humanities
(30)
Literature, Romance
(30)
Diabetes Mellitus, Type 2 - Drug Therapy
(28)
Insulin
(27)
Aged
(23)
Hypoglycemic Agents - Therapeutic Use
(21)
Diabetes Mellitus, Type 1 - Drug Therapy
(20)
Hypoglycemic Agents - Administration & Dosage
(20)
Blood Glucose - Metabolism
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3

Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action

Primary care physician beliefs about insulin initiation in patients with type 2 diabetes

Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial

A randomized clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 1

Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes

A randomized clinical trial of basal insulin peglispro vs NPH in insulin-naïve patients with type 2 diabetes: the IMAGINE 6 trial

Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes

Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes

A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetes

Glucodynamics of long-acting basal insulin peglispro compared with insulin glargine at steady state in patients with type 1 diabetes: substudy of a randomized crossover trial

Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycaemic control in T1DM and T2DM

CA-013: Réduction des hypoglycémies nocturnes avec l'insuline basale peglispro (BIL) comparée à l'insuline glargine (GL) : analyses poolées de 5 études contrôlées randomisées

Addition of insulin lispro protamine suspension or insulin glargine to oral type 2 diabetes regimens: a randomized trial

CA-018: Enzymes hépatiques et contenu hépatique en graisse (CHG) – Résultats des essais cliniques de l'insuline Peligspro (BIL)

PO31 Amélioration du contrôle glycémique avec l’insuline basale LY2605541 comparée à l’insuline basale glargine malgré une réduction des doses des bolus d’insuline chez des patients présentant un diabète de type 1

A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents

Diabetes and pregnancy. Factors associated with seeking pre-conception care

Why Do Older Women with Diabetes Have an Increased Fracture Risk?

Cardiovascular Disease in the Diabetic Woman

The influence of treatment modality and ethnicity on attitudes in type 2 diabetes

The safety of injecting insulin through clothing

Altered myosin light-chain phosphorylation in resting platelets from premenopausal women with diabetes

Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

An update on perioperative management of diabetes

Suchergebnisse filtern